메뉴 건너뛰기




Volumn 49, Issue 1 SUPPL., 1997, Pages

Pharmacologic profile of ropinirole: A nonergoline dopamine agonist

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; PERGOLIDE; ROPINIROLE; TALIPEXOLE;

EID: 0030835297     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.49.1_suppl_1.s58     Document Type: Article
Times cited : (94)

References (35)
  • 1
    • 0014673226 scopus 로고
    • Modification of parkinsonism: Chronic treatment with L-dopa
    • Cotzias GC, Papavasiliou PS, Gellene R. Modification of parkinsonism: chronic treatment with L-dopa. N Engl J Med 1969;280:337-345.
    • (1969) N Engl J Med , vol.280 , pp. 337-345
    • Cotzias, G.C.1    Papavasiliou, P.S.2    Gellene, R.3
  • 2
    • 0023157703 scopus 로고
    • Akathesia in idiopathic Parkinson's disease
    • Lang AE, Johnson K. Akathesia in idiopathic Parkinson's disease. Neurology 1987;37:477-481.
    • (1987) Neurology , vol.37 , pp. 477-481
    • Lang, A.E.1    Johnson, K.2
  • 3
    • 0017840794 scopus 로고
    • Onset and end-of-dose levodopa-induced dyskinesias: Possible treatment by increasing the daily dose of levodopa
    • Lhermitte F, Agid Y, Signoret JL. Onset and end-of-dose levodopa-induced dyskinesias: possible treatment by increasing the daily dose of levodopa. Arch Neurol 1978;35:261-263.
    • (1978) Arch Neurol , vol.35 , pp. 261-263
    • Lhermitte, F.1    Agid, Y.2    Signoret, J.L.3
  • 4
    • 0017468670 scopus 로고
    • Patterns of dystonia ("I-D-I" and "D-I-D") in response to L-dopa therapy for Parkinson's disease
    • Muenter MD, Sharpless NS, Tyce GM, Darley FL. Patterns of dystonia ("I-D-I" and "D-I-D") in response to L-dopa therapy for Parkinson's disease. Mayo Clin Proc 1977;52:163-174.
    • (1977) Mayo Clin Proc , vol.52 , pp. 163-174
    • Muenter, M.D.1    Sharpless, N.S.2    Tyce, G.M.3    Darley, F.L.4
  • 5
    • 0025355032 scopus 로고
    • Levodopa-induced dyskinesias: Review, observations, and speculations
    • Nutt JG. Levodopa-induced dyskinesias: review, observations, and speculations. Neurology 1990;40:340-345.
    • (1990) Neurology , vol.40 , pp. 340-345
    • Nutt, J.G.1
  • 6
    • 84984145377 scopus 로고
    • Problems associated with long-term levodopa treatment of Parkinson's disease
    • Rinne UK. Problems associated with long-term levodopa treatment of Parkinson's disease. Acta Neurol Scand 1983; 95(Suppl):19-26.
    • (1983) Acta Neurol Scand , vol.95 , Issue.SUPPL. , pp. 19-26
    • Rinne, U.K.1
  • 8
    • 0013610466 scopus 로고
    • The novel dopaminergic agent ropinirole selectively binds to cloned dopamine D3 receptors
    • Fears R, Bowen WP, Brown F, et al. The novel dopaminergic agent ropinirole selectively binds to cloned dopamine D3 receptors. Can J Neurol Sci 1993;20(Suppl 4):S68.
    • (1993) Can J Neurol Sci , vol.20 , Issue.4 SUPPL.
    • Fears, R.1    Bowen, W.P.2    Brown, F.3
  • 9
    • 0028971356 scopus 로고
    • Ropinirole in the symptomatic treatment of Parkinson's disease
    • Brooks DJ, Torjansk N, Burn DJ. Ropinirole in the symptomatic treatment of Parkinson's disease. J Neural Transm Suppl 1995;45:231-238.
    • (1995) J Neural Transm Suppl , vol.45 , pp. 231-238
    • Brooks, D.J.1    Torjansk, N.2    Burn, D.J.3
  • 11
    • 0027518471 scopus 로고
    • Subtypes and localization of dopamine receptors in human brain
    • De Keyser J. Subtypes and localization of dopamine receptors in human brain. Neurochem Int 1993;22:83-93.
    • (1993) Neurochem int , vol.22 , pp. 83-93
    • De Keyser, J.1
  • 12
    • 0029895570 scopus 로고    scopus 로고
    • Comparative review of dopamine receptor agonists in Parkinson's disease
    • Uitti RJ, Ahlskog JE. Comparative review of dopamine receptor agonists in Parkinson's disease. CNS Drugs 1996;5:369-387.
    • (1996) CNS Drugs , vol.5 , pp. 369-387
    • Uitti, R.J.1    Ahlskog, J.E.2
  • 13
    • 0027500750 scopus 로고
    • Treatment of Parkinson's disease
    • Calne DB. Treatment of Parkinson's disease. N Engl J Med 1993;329:1021-1027.
    • (1993) N Engl J Med , vol.329 , pp. 1021-1027
    • Calne, D.B.1
  • 14
    • 0001904937 scopus 로고
    • Drugs for Parkinson's disease, spasticity, and acute muscle spasms
    • Gilman AG, Rail TW, Nies AS, Taylor P, eds. New York: McGraw-Hill
    • Cedarbaum JM, Schleifer LS. Drugs for Parkinson's disease, spasticity, and acute muscle spasms. In: Gilman AG, Rail TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. New York: McGraw-Hill 1993;463-484.
    • (1993) Goodman and Gilman's the Pharmacological Basis of Therapeutics, 8th Ed. , pp. 463-484
    • Cedarbaum, J.M.1    Schleifer, L.S.2
  • 15
    • 0019307736 scopus 로고
    • The role of D-1 and D-2 receptors
    • Schachter M, Bédard P, Debono AG, et al. The role of D-1 and D-2 receptors. Nature 1980;286:157-159.
    • (1980) Nature , vol.286 , pp. 157-159
    • Schachter, M.1    Bédard, P.2    Debono, A.G.3
  • 17
    • 0027160043 scopus 로고
    • Glutamate-dopamine interactions in the basal ganglia: Relationship to Parkinson's disease
    • Greenamyre JT. Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease. J Neural Transm Gen Sect 1993;91:255-269.
    • (1993) J Neural Transm Gen Sect , vol.91 , pp. 255-269
    • Greenamyre, J.T.1
  • 19
    • 0029269229 scopus 로고
    • The rationale for the use of dopamine agonists in Parkinson's disease
    • Jenner P. The rationale for the use of dopamine agonists in Parkinson's disease. Neurology 1995;45(Suppl 3):S6-S12.
    • (1995) Neurology , vol.45 , Issue.3 SUPPL.
    • Jenner, P.1
  • 20
    • 0028971703 scopus 로고
    • Dopaminergic agonists in the treatment of Parkinson's disease: A review
    • Piccoli F, Riuggeri RM. Dopaminergic agonists in the treatment of Parkinson's disease: a review. J Neural Transm Suppl 1995;45:187-195.
    • (1995) J Neural Transm Suppl , vol.45 , pp. 187-195
    • Piccoli, F.1    Riuggeri, R.M.2
  • 21
    • 0026590683 scopus 로고
    • Dopaminergic agonists in the treatment of Parkinson's disease
    • Goetz CG, Diederich NJ. Dopaminergic agonists in the treatment of Parkinson's disease. Neurol Clin 1992;10:527-540.
    • (1992) Neurol Clin , vol.10 , pp. 527-540
    • Goetz, C.G.1    Diederich, N.J.2
  • 22
    • 0002762924 scopus 로고
    • Pharmacodynamics: Mechanisms of drug action and the relationship between drug concentration and effect
    • Gilman AG, Rail TW, Nies AS, Taylor P, eds. New York: McGraw-Hill
    • Ross EM. Pharmacodynamics: mechanisms of drug action and the relationship between drug concentration and effect. In: Gilman AG, Rail TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. New York: McGraw-Hill, 1993:33-48.
    • (1993) Goodman and Gilman's the Pharmacological Basis of Therapeutics, 8th Ed. , pp. 33-48
    • Ross, E.M.1
  • 23
    • 0022658363 scopus 로고
    • Selectivity of some ergot derivatives for 5-HT1 and 5-HT2 receptors of rat cerebral cortex
    • Beart PM, McDonald D, Cincotta M, de Vries DJ, Gundlach AL. Selectivity of some ergot derivatives for 5-HT1 and 5-HT2 receptors of rat cerebral cortex. Gen Pharmacol 1986;17:57-62.
    • (1986) Gen Pharmacol , vol.17 , pp. 57-62
    • Beart, P.M.1    McDonald, D.2    Cincotta, M.3    De Vries, D.J.4    Gundlach, A.L.5
  • 24
    • 84940137804 scopus 로고
    • Differential binding of ergot compounds to human versus rat 5-HT2 cortical receptors
    • Hagen JD, Pierce PA, Peroutka SJ. Differential binding of ergot compounds to human versus rat 5-HT2 cortical receptors. Biol Signals 1994;3:223-229.
    • (1994) Biol Signals , vol.3 , pp. 223-229
    • Hagen, J.D.1    Pierce, P.A.2    Peroutka, S.J.3
  • 25
    • 0025317247 scopus 로고
    • Pergolide: A review of its pharmacological potential in Parkinson's disease
    • Langtry HD, Clissold SP. Pergolide: a review of its pharmacological potential in Parkinson's disease. Drugs 1990;39:491-506.
    • (1990) Drugs , vol.39 , pp. 491-506
    • Langtry, H.D.1    Clissold, S.P.2
  • 26
    • 0021352630 scopus 로고
    • In vitro selectivity of lisuride and other ergot derivatives for alpha 1- and alpha 2-adrenoceptors
    • McPherson GA. In vitro selectivity of lisuride and other ergot derivatives for alpha 1- and alpha 2-adrenoceptors. Eur J Pharmacol 1984;97:151-155.
    • (1984) Eur J Pharmacol , vol.97 , pp. 151-155
    • McPherson, G.A.1
  • 27
    • 0029025270 scopus 로고
    • Dopamine agonists in the treatment of Parkinson's disease
    • Pahwa R, Koller WC. Dopamine agonists in the treatment of Parkinson's disease. Cleve Clin J Med 1995;62:212-217.
    • (1995) Cleve Clin J Med , vol.62 , pp. 212-217
    • Pahwa, R.1    Koller, W.C.2
  • 29
    • 0018380212 scopus 로고
    • Effects of ergot drugs on serotonergic function: Behaviour and neurochemistry
    • Silberbergeld EK, Hruska RE. Effects of ergot drugs on serotonergic function: behaviour and neurochemistry. Eur J Pharmacol 1979;58:1-10.
    • (1979) Eur J Pharmacol , vol.58 , pp. 1-10
    • Silberbergeld, E.K.1    Hruska, R.E.2
  • 33
    • 0030741788 scopus 로고    scopus 로고
    • Attempts to obtain neuroprotection in Parkinson's disease
    • Olanow CW. Attempts to obtain neuroprotection in Parkinson's disease. Neurology 1997;49(Suppl 1):S26-S33.
    • (1997) Neurology , vol.49 , Issue.1 SUPPL.
    • Olanow, C.W.1
  • 34
    • 0002852574 scopus 로고    scopus 로고
    • Effects of repeated treatment with L-dopa, bromocriptine and ropinirole in drug naive MPTP-treated common marmosets
    • Pearce RKB, Banerji T, Jenner P, Marsden CD. Effects of repeated treatment with L-dopa, bromocriptine and ropinirole in drug naive MPTP-treated common marmosets [abstract]. Br J Pharmacol 1996;118:37P.
    • (1996) Br J Pharmacol , vol.118
    • Pearce, R.K.B.1    Banerji, T.2    Jenner, P.3    Marsden, C.D.4
  • 35
    • 0017690811 scopus 로고
    • Investigations into the nature of the peri-oral movements induced by 2-(N,N-dipropyl) amino-5,6-dihydroxytetraline
    • Costall B, Naylor RJ, Owen RT. Investigations into the nature of the peri-oral movements induced by 2-(N,N-dipropyl) amino-5,6-dihydroxytetraline. Eur J Pharmacol 1977;45:357-367.
    • (1977) Eur J Pharmacol , vol.45 , pp. 357-367
    • Costall, B.1    Naylor, R.J.2    Owen, R.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.